(Q34625452)

English

How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

4 references

23 March 2019

31 July 2019

19 September 2019

23 October 2022

0 references

How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

immunologic test

1 reference

31 July 2019

biomedical investigative technique

1 reference

19 September 2019

systematic review

1 reference

based on heuristic

inferred from title

4

object named as

Dick Menzies

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Olivia Oxlade

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Marcia Pinto

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Anete Trajman

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

7 March 2013

5 references

Europe PubMed Central

PubMed publication ID

3 August 2017

23 March 2019

31 July 2019

19 September 2019

23 October 2022

5 references

Europe PubMed Central

PubMed publication ID

3 August 2017

23 March 2019

31 July 2019

19 September 2019

23 October 2022

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

e56044

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

4 references

Europe PubMed Central

23 March 2019

Europe PubMed Central

31 July 2019

Europe PubMed Central

19 September 2019

Europe PubMed Central

23 October 2022

copyright status

0 references

Systematic review of cost and cost-effectiveness of different TB-screening strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

7 July 2018

Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

7 July 2018

Priorities for screening and treatment of latent tuberculosis infection in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

7 July 2018

Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

7 July 2018

Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

7 July 2018

Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

7 July 2018

Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

7 July 2018

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

7 July 2018

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

7 July 2018

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

7 July 2018

Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0056044

21 January 2018

Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0056044

21 January 2018

Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-α antagonist therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

26 October 2018

Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

26 October 2018

Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591384

26 October 2018

Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23505412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/23505412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/23505412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts

1 reference

https://pubmed.ncbi.nlm.nih.gov/23505412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23505412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0056044

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2013PLoSO...856044O

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34625452&oldid=1756505609"